Ignite Creation Date:
2025-12-25 @ 1:27 AM
Ignite Modification Date:
2025-12-27 @ 11:51 PM
Study NCT ID:
NCT01256593
Status:
COMPLETED
Last Update Posted:
2023-09-15
First Post:
2010-12-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety And Efficacy Of Lyrica (Regulatory Post Marketing Commitment Plan)
Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-02-05
Start Date Type:
ACTUAL
Primary Completion Date:
2017-07-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-07-31
Completion Date Type:
ACTUAL
First Submit Date:
2010-12-07
First Submit QC Date:
None
Study First Post Date:
2010-12-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-07-23
Results First Submit QC Date:
None
Results First Post Date:
2019-05-07
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-08-21
Last Update Post Date:
2023-09-15
Last Update Post Date Type:
ACTUAL